Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Capsaicin cream versus mometasone cream for macular amyloidosis
IRCT20230307057646N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of capsaicin, mometasone and desloratadine in Macular Amyloidosis (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Lesion size, Physician satisfaction and 4 more. Started Nov 2024; status: completed.
02
Drugs
capsaicinmometasonedesloratadine
03
Conditions
Macular Amyloidosis
Beyond the preview
Go deeper on IRCT20230307057646N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20230307057646N3.